The Influences of Caffeine on Heart Rate Variability of Preterm Infants
NCT ID: NCT01769118
Last Updated: 2015-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2013-01-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Caffeine on Heart Rate Variability in Newborns
NCT04869176
Caffeine as Respiratory Stimulant in Preterm Infants
NCT04144712
Effect of Early Use of Caffeine Citrate in Preterm Neonates
NCT04001712
Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants
NCT01819064
Cardiac Autonomic Reactivity and Behavioral Response to Pain in Full-Term Neonates
NCT00396838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Caffeine
caffeine will be given according to clinical judgment
Caffeine
Caffeine will be given according to departmental protocol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Caffeine
Caffeine will be given according to departmental protocol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* congenital malformations
25 Weeks
34 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
wamir
Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RMC
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0442-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.